Checkmate Therapeutics
Seoul, South Korea · Founded 2019
- Headquarters
- Seoul
- Employees
- 1–10
- Founded
- 2019
- Business Model
- B2B
- Website
- checkmatetx.com
About
Checkmate Therapeutics is a Seoul-based biopharmaceutical company founded in 2019 focused on discovering and developing first-in-class therapies for metastatic and difficult-to-treat cancers. The company employs novel target-based drug discovery approaches to identify innovative therapeutics for patients suffering from cancer and other incurable diseases. Founded by Professor Hyun Seok Kim of Yonsei University College of Medicine, who serves as Founder and CSO, the company bridges academic oncology research with translational drug development. Checkmate Therapeutics operates at the early stage of the drug discovery pipeline with a focus on targeted cancer therapies.
Summary
Checkmate Therapeutics is a Biotech company based in Seoul, South Korea, founded in 2019.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company